EverQuote, Inc. (EVER)
Automate Your Wheel Strategy on EVER
With Tiblio's Option Bot, you can configure your own wheel strategy including EVER - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EVER
- Rev/Share 16.9363
- Book/Share 4.6871
- PB 4.1284
- Debt/Equity 0.0186
- CurrentRatio 3.0274
- ROIC 0.2525
- MktCap 706439456.0
- FreeCF/Share 2.4736
- PFCF 7.8616
- PE 15.1002
- Debt/Assets 0.0131
- DivYield 0
- ROE 0.3251
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 3
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | EVER | Raymond James | Strong Buy | Outperform | -- | $30 | Sept. 22, 2025 |
| Upgrade | EVER | Raymond James | Outperform | Strong Buy | -- | $35 | Dec. 26, 2024 |
News
EverQuote (EVER) Loses 23.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Negative
EverQuote (EVER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
Read More
Root vs. EverQuote: Which Stock Is the Stronger Bet in Insurtech?
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote's debt-free growth strategy and AI-powered platform position it well compared to Root in the insurtech race.
Read More
EVER Rallies 16.3% YTD, Trades at Premium: Should You Buy the Stock?
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
EverQuote leans on AI, data and a stronger auto focus to drive growth, but faces rising costs, stiff competition and regulatory risks.
Read More
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Neutral
EVER trades above its 200-day SMA with strong returns and rising quote requests, though challenges remain ahead.
Read More
EverQuote Announces $21 Million Repurchase of Shares from Link Ventures and Affiliated Entities Controlled by Chairman and Co-Founder, David Blundin
Published: August 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Enables EverQuote to efficiently execute a portion of its $50 million Share Repurchase Program Mr. Blundin remains EverQuote's Chairman and largest shareholder CAMBRIDGE, Mass.
Read More
Wall Street Analysts Predict a 36.57% Upside in EverQuote (EVER): Here's What You Should Know
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
EverQuote: New Buybacks Signal A Very Healthy Business
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Positive
I remain bullish on EverQuote, viewing the post-earnings dip as a compelling buy opportunity given strong long-term growth catalysts and a healthy balance sheet. EverQuote targets $1 billion in annual revenue and 20% adjusted EBITDA margins, leveraging AI and product expansion to drive efficiency and profitability. Despite a Q2 revenue miss, auto insurance demand remains robust, and variable marketing margins have stabilized, signaling a profitable steady-state environment.
Read More
EverQuote Q2 Earnings & Revenues Beat on Higher Automotive Revenues
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
EVER's second-quarter results reflect solid performances across both Automotive insurance and Home and Renters insurance verticals, offset by higher expenses.
Read More
EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
Read More
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Positive
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.
Read More
4 Growth Stocks From the Insurance Space to Add to Your Portfolio
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Given the prospects of the insurance industry, EVER, HMN, ROOT and HCI have the potential to generate better returns than other players.
Read More
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Read More
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Add INTU, NVMI, EVER and SEZL to your watchlist as each boasts strong liquidity, growth attributes and operational efficiency.
Read More
Wall Street Analysts See a 38.85% Upside in EverQuote (EVER): Can the Stock Really Move This High?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for EverQuote (EVER) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
EverQuote (EVER) Up 4.8% Since Last Earnings Report: Can It Continue?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock?
Read More
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Read More
Wall Street Analysts Think EverQuote (EVER) Could Surge 42.43%: Read This Before Placing a Bet
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 42.4% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Read More
4 Top-Ranked Liquid Stocks to Bet on for Boosting Portfolio Returns
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors can boost returns by adding top-ranked liquid stocks such as Avino Silver, Pagaya Technologies, EverQuote and Sezzle to their portfolios.
Read More
EverQuote: Stock With Above-Average Gain Potential
Published: May 12, 2025 by: Seeking Alpha
Sentiment: Positive
EverQuote's technology efficiently matches pre-validated consumers with insurance providers, optimizing marketing spend and ROI for insurers. The fragmented P&C insurance market presents a significant growth opportunity for the Company, addressing inefficiencies in consumer-provider matching and advertising channels. EVER's above-average growth can drive strong annual stock gains from the reasonable valuation level.
Read More
EverQuote's Q1 Earnings & Revenues Beat, Automotive Vertical Grows
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
EVER's first-quarter results mark the fourth straight quarter of record revenue and adjusted EBITDA performance. All the verticles showed improvement.
Read More
EverQuote: Auto Insurance Carriers Are Still Revving Up Growth
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
EverQuote's Q1 results showed rapid revenue and variable marketing dollar growth, alongside a tripling of adjusted EBITDA. Despite recent outperformance, EverQuote remains reasonably valued at ~11x forward adjusted EBITDA, offering a great hedge against an expensive market. Risks include a potential slowdown in auto insurance carriers' appetite for expansion if tariffs drive higher part replacement costs, but this is already reflected in EverQuote's low share price.
Read More
EverQuote, Inc. (EVER) Q1 2025 Earnings Call Transcript
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral
EverQuote, Inc. (NASDAQ:EVER ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Jayme Mendal - Chief Executive Officer Joseph Sanborn - Chief Financial Officer Brinlea Johnson - The Blueshirt Group, IR Conference Call Participants Maria Ripps - Canaccord Genuity Jason Kreyer - Craig Hallum Zach Cummins - B. Riley Ralph Schackart - William Blair Mayank Tandon - Needham Jed Kelly - Oppenheimer Mitch Rubin - Raymond James Operator Presentation Operator Good afternoon, ladies and gentlemen.
Read More
EverQuote Gears Up to Report Q1 Earnings: What to Expect
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
EVER's first-quarter results are likely to reflect benefit from auto insurance and homeowners' insurance market recovery, as well as improved operational efficiency.
Read More
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Published: April 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Read More
4 Top-Performing Liquid Stocks to Strengthen Portfolio Returns
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors can boost returns by adding top-ranked liquid stocks such as Avino Silver, CommScope, EverQuote and Willdan to their portfolios.
Read More
Is EverQuote (EVER) Stock a Solid Choice Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote (EVER) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Read More
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Positive
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
Read More
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), EMCOR Group (EME), Expeditors International of Washington (EXPD) and Sprouts Farmers Market (SFM).
Read More
About EverQuote, Inc. (EVER)
- IPO Date 2018-06-28
- Website https://www.everquote.com
- Industry Internet Content & Information
- CEO Jayme Mendal
- Employees 324